Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Volitionrx (VNRX) Non-Current Deffered Revenue (2024 - 2025)

Volitionrx's Non-Current Deffered Revenue history spans 2 years, with the latest figure at $21.9 million for Q4 2025.

  • For Q4 2025, Non-Current Deffered Revenue fell 3.2% year-over-year to $21.9 million; the TTM value through Dec 2025 reached $21.9 million, down 3.2%, while the annual FY2025 figure was $21.9 million, 3.2% down from the prior year.
  • Non-Current Deffered Revenue reached $21.9 million in Q4 2025 per VNRX's latest filing, roughly flat from $22.0 million in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $22.7 million in Q4 2024 to a low of $21.9 million in Q4 2025.